Bionure appoints Laurent Nguyen as CEO

by Gemma Escarré,

Bionure, a biotech company specialized in neuroprotection member of CataloniaBio & HealthTech, announces the appointment of Dr. Laurent Nguyen as the new CEO and strengthens its scientific team with the arrival of Dr. Amit Bar-Or, a multiple sclerosis specialist.

Nguyen is doctor in Medicine and has a solid experience in the pharmaceutical industry at Hoechst-Roussel, Merck, F. Hoffmann-La Roche and Pierre Fabre. He then moved to the biotech sector where he became CEO of a French academic spin-off that he developed into a publicly traded clinical biotech company.

The ongoing Phase I clinical trial of its neuroprotective and remyelinating compound BN201 is due for completion early 2019.

More information

Photo: Laurent Nguyen - Bionure

Comments


To comment, please login or create an account